NSEStatement of deviation(s) or variation(s) under Reg. 32Fundraise29 Oct 2026
Steamhouse India Limited
Statement of deviation(s) or variation(s) under Reg. 32
Steamhouse India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there has been no deviation or variation in the utilisation of the IPO proceeds from the objects stated in the Prospectus of the Company.
BSECompany UpdateFundraise29 Oct 2026
Ugro Capital Ltd
Allotment of Commercial Papers
Ugro Capital Ltd has informed about the allotment of Commercial Papers as per the particulars furnished in 'Annexure'. The allotment was approved by the Investment and Borrowing Committee of the Board of Directors on October 29, 2026.
BSECompany UpdateFundraise29 Oct 2026
Avenue Supermarts Ltd
The Company has allotted Commercial Paper of Rs. 200 crores
Avenue Supermarts Ltd has allotted Commercial Paper of Rs. 200 crores with a tenure of 43 days, carrying a coupon rate of 7.20% and ICRA A1+ credit rating.
BSECompany UpdateFundraise29 Oct 2026
Avio Smart Market Stack Ltd
Avio Smart Market Stack Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve various matters in connection with the proposed Rights Issue of equity shares of the Company for an amount not exceedin Rs. 49,00,00,000/-.
In this regard, we wish to inform you that the Company had submitted the requisite applications to BSE Limited and NSE for obtaining in-principal ....
Avio Smart Market Stack Ltd has postponed its Board Meeting scheduled for October 29, 2026, to consider the proposed Rights Issue due to the Stock Exchanges' queries on the Draft Letter of Offer.
NSEGeneral UpdatesFundraise29 Oct 2026
Avenue Supermarts Limited
General Updates
Avenue Supermarts Limited has informed the Exchange about the allotment of Commercial Paper of Rs. 200 crores, with a tenure of 43 days and a coupon rate of 7.20%.
NSEStatement of deviation(s) or variation(s) under Reg. 32Fundraise29 Oct 2026
Senores Pharmaceuticals Limited
Statement of deviation(s) or variation(s) under Reg. 32
Senores Pharmaceuticals Limited has submitted a statement of deviation(s) or variation(s) under Reg. 32 to the Exchange regarding the utilization of funds raised through a preferential issue of convertible equity warrants for the quarter ended September 30, 2026. The company confirms that there has been no deviation(s) or variation(s) in the utilization of the funds raised for the objects stated in the explanatory statement to the Notice of the Extra-ordinary General Meeting held on January 31, 2026.
BSECompany UpdateFundraise29 Oct 2026
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, at ₹157.27 per share.
BSECompany UpdateFundraise29 Oct 2026
Ishaan Infrastructures and Shelters Ltd
Novus Capital Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-offer advertisement in accordance under Regulation 18(7) in terms of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended and Corrigendum to the Detailed Public Announcement with respect to the open offer to the public shareholders of Ishaan Infrastructures and Shelters Ltd ("Target Company").
Ishaan Infrastructures and Shelters Ltd has received a copy of Pre-offer advertisement from Novus Capital Advisors Pvt Ltd, the Manager to the Offer, under Regulation 18(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended, and a Corrigendum to the Detailed Public Announcement with respect to the open offer to the public shareholders.
BSECompany UpdateFundraise29 Oct 2026
Anlon Healthcare Ltd
We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.
Kindly take the same on your record.
Thank you.
Anlon Healthcare Ltd has received 'In-Principle' approval from NSE and BSE for the proposed issuance of 8,05,35,651 equity shares on a preferential basis.
NSECopy of Newspaper PublicationFundraise29 Oct 2026
Natco Pharma Limited
Copy of Newspaper Publication
Natco Pharma Limited has informed the Exchange about Copy of News Paper Publication of Basis of Allotment for Rights Issue.
BSECompany UpdateFundraise29 Oct 2026
63 Moons Technologies Ltd
Intimation for execution of Warrant Subscription Agreement by our material subsidiary, 63SATS Cybertech Limited with Bennett Coleman and Company Limited
63 Moons Technologies Ltd has informed that its material subsidiary, 63SATS Cybertech Limited, has entered into a Warrant Subscription Agreement with Bennett Coleman and Company Limited to facilitate a staged capital infusion.
NSEAgreementsFundraise29 Oct 2026
63 moons technologies limited
Agreements
63 Moons Technologies Limited has informed the Exchange about Agreements, specifically a Warrant Subscription Agreement between its material subsidiary, 63SATS Cybertech Limited, and Bennett Coleman and Company Limited. The agreement is intended to facilitate a staged capital infusion, optimize shareholder value, and strengthen 63SATS' corporate positioning and brand visibility.
NSEUpdatesFundraise29 Oct 2026
Anlon Healthcare Limited
Updates
Anlon Healthcare Limited has received 'In-Principle' approval from NSE and BSE for the proposed issuance of 8,05,35,651 equity shares on a preferential basis.
BSECompany UpdateFundraise29 Oct 2026
Natco Pharma Ltd
News Paper Publication for Basis of Allotment of Right Issue
Natco Pharma Ltd has published the basis of allotment of its rights issue in newspapers as per SEBI regulations.
BSEBoard MeetingFundraise29 Oct 2026
Arvaya Healthcare Ltd
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1. To consider and approve the proposed objects and utilisation of proceeds of the Rights Issue, including the proposed deployment of funds towards the objects set out in the Draft Letter of Offer.
2. To consider and approve the Draft Letter of Offer ('DLOF') in connection with the proposed ....
Arvaya Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/11/2026 to consider and approve the proposed objects and utilisation of proceeds of the Rights Issue, Draft Letter of Offer, and material related party transactions.
NSEMonitoring Agency ReportFundraise29 Oct 2026
P N Gadgil Jewellers Limited
Monitoring Agency Report
P N Gadgil Jewellers Limited has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, issued by India Ratings and Research Private Limited, indicating no deviation from the objects of the Qualified Institutions Placement (QIP) issue.
BSECompany UpdateFundraise29 Oct 2026
P N Gadgil Jewellers Ltd
Monitoring Agency Report for the Quarter ended September 30, 2026
P N Gadgil Jewellers Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, as per SEBI regulations, indicating no deviation from the objects of the QIP issue.
BSECompany UpdateFundraise29 Oct 2026
Lloyds Metals and Energy Ltd
Intimation for Allotment of U.S Dollar Denominated Notes.
Lloyds Metals and Energy Ltd has announced the allotment of USD 130 million senior secured floating rate bonds with a 3-year tenor, to be redeemed in 2029. The bonds will be listed on an unlisted platform and will have a coupon rate of 3 Month Term SOFR + 4.5% margin.
NSEAllotment of SecuritiesFundraise29 Oct 2026
Lloyds Metals And Energy Limited
Allotment of Securities
Lloyds Metals and Energy Limited has announced the allotment of USD 130 million senior secured floating rate bonds with a 3-year tenor and a coupon rate of 3 Month Term SOFR + 4.5% margin.
BSEGeneralFundraise29 Oct 2026
Ambassador Intra Holdings Ltd
Outcome of Board meeting for receiving the 3rd tranche consideration for allotment of warrants of Convertible Warrants.
Ambassador Intra Holdings Ltd has informed about the outcome of its Board meeting held on 29th October, 2026, where the Board approved the receipt of the 3rd tranche consideration for allotment of warrants of Convertible Warrants.